vimarsana.com

விஞ்ஞானிகள் இல் வாஷிங்டன் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ANGLE PLC hails research which underlines liquid biopsy s potential in breast cancer

Immune cell implicated in development of lung disease following viral infection

Immune cell implicated in development of lung disease following viral infection Findings could help explain how asthma, COPD, severe COVID-19 are triggered Holtzman Lab A new study from Washington University School of Medicine in St. Louis implicates a type of immune cell called a dendritic cell in the development of chronic lung diseases that can follow after a respiratory viral infection. Shown is a stained section of mouse lung. Epithelial cells, which line the airway, are red. Dendritic cells are green. Any cell nuclei are blue. Newswise Scientists at Washington University School of Medicine in St. Louis have implicated a type of immune cell in the development of chronic lung disease that sometimes is triggered following a respiratory viral infection. The evidence suggests that activation of this immune cell a type of guardian cell called a dendritic cell serves as an early switch that, when activated, sets in motion a chain of events that drives progressive lung d

Immune Cell Implicated in Post-Viral Lung Disease

New study may lead to therapeutic strategies for chronic lung disease

New study may lead to therapeutic strategies for chronic lung disease Scientists at Washington University School of Medicine in St. Louis have implicated a type of immune cell in the development of chronic lung disease that sometimes is triggered following a respiratory viral infection. The evidence suggests that activation of this immune cell a type of guardian cell called a dendritic cell serves as an early switch that, when activated, sets in motion a chain of events that drives progressive lung diseases, including asthma and chronic obstructive pulmonary disease (COPD). The new study, published in The Journal of Immunology, opens the door to potential preventive or therapeutic strategies for chronic lung disease. More immediately, measuring the levels of these dendritic cells in clinical samples from patients hospitalized with a viral infection, such as influenza or COVID-19, could help doctors identify which patients are at high risk of respiratory failure and death.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.